Phibro Animal Health (PAHC) Other financing activities (2022 - 2024)

Phibro Animal Health (PAHC) recorded quarterly Other financing activities of $10.4 million in Q3 2024, up 1145.74% quarter-over-quarter from $833000.0 in Q2 2023.

Phibro Animal Health (PAHC) Other financing activities (2022 - 2024) Analysis & Trends

Phibro Animal Health's Other financing activities history runs 3 years deep, the most recent figure standing at $10.4 million for Q3 2024.

  • In Q3 2024, Other financing activities changed N/A year-over-year to $10.4 million; the TTM figure through Jun 2025 stood at $10.4 million (changed N/A YoY), while the FY2025 annual figure was $10.4 million, changed N/A from the prior year.
  • Other financing activities was $10.4 million for Q3 2024 at Phibro Animal Health, up from $833000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $10.4 million in Q3 2024 to a low of $71000.0 in Q3 2022.
  • Historically, Other financing activities has averaged $3.0 million across 3 years, with a median of $701000.0 in 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Phibro Animal Health 1.32 Bn 1.24 Bn 125.68 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 10.38 Mn
Sep 30, 2024 10.38 Mn
Jun 30, 2023 833,000.00
Jun 30, 2023 833,000.00
Dec 31, 2022 569,000.00
Dec 31, 2022 569,000.00
Sep 30, 2022 71,000.00
Sep 30, 2022 71,000.00